Download PDF
Digestive Disease Interventions
DOI: 10.1055/s-0044-1787568
Review Article

Palliative Interventions in Advanced Cholangiocarcinoma

Anthony S. Tadros 
1   Division of Vascular and Interventional Radiology, Department of Radiology, University of California San Diego, San Diego, California
,
Sean Tutton
1   Division of Vascular and Interventional Radiology, Department of Radiology, University of California San Diego, San Diego, California
,
Jonas Redmond
1   Division of Vascular and Interventional Radiology, Department of Radiology, University of California San Diego, San Diego, California
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Patients with advanced cholangiocarcinoma have poor prognosis and often experience severe tumor-related symptoms. Malignant biliary obstruction and cancer pain are common complications associated with advanced cholangiocarcinoma. We review percutaneous palliative interventions that can improve quality of life for these patients.

Keywords

biliary obstruction - cancer pain - palliative intervention - ablation


Publication History

Received: 22 April 2024

Accepted: 09 May 2024

Article published online:
27 June 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Plentz RR, Malek NP. Clinical presentation, risk factors and staging systems of cholangiocarcinoma. Best Pract Res Clin Gastroenterol 2015; 29 (02) 245-252
    CrossrefPubMedGoogle Scholar
  • 2 Jansen H, Pape UF, Utku N. A review of systemic therapy in biliary tract carcinoma. J Gastrointest Oncol 2020; 11 (04) 770-789
    CrossrefPubMedGoogle Scholar
  • 3 Valle JW, Borbath I, Khan SA, Huguet F, Gruenberger T, Arnold D. ESMO Guidelines Committee. Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016; 27 (Suppl. 05) v28-v37
    CrossrefPubMedGoogle Scholar
  • 4 Hunter LA, Soares HP. Quality of life and symptom management in advanced biliary tract cancers. Cancers (Basel) 2021; 13 (20) 5074
    CrossrefPubMedGoogle Scholar
  • 5 Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2011; 8 (09) 512-522
    CrossrefPubMedGoogle Scholar
  • 6 Covey AM, Brown KT. Palliative percutaneous drainage in malignant biliary obstruction. Part 1: indications and preprocedure evaluation. J Support Oncol 2006; 4 (06) 269-273
    PubMedGoogle Scholar
  • 7 Andersen JR, Sørensen SM, Kruse A, Rokkjaer M, Matzen P. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 1989; 30 (08) 1132-1135
    CrossrefPubMedGoogle Scholar
  • 8 Lai EC, Chu KM, Lo CY, Fan ST, Lo CM, Wong J. Choice of palliation for malignant hilar biliary obstruction. Am J Surg 1992; 163 (02) 208-212
    CrossrefPubMedGoogle Scholar
  • 9 Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 1994; 344 (8938): 1655-1660
    CrossrefPubMedGoogle Scholar
  • 10 Paik WH, Park YS, Hwang JH. et al. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc 2009; 69 (01) 55-62
    CrossrefPubMedGoogle Scholar
  • 11 Piñol V, Castells A, Bordas JM. et al. Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial. Radiology 2002; 225 (01) 27-34
    CrossrefPubMedGoogle Scholar
  • 12 Saluja SS, Gulati M, Garg PK. et al. Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment. Clin Gastroenterol Hepatol 2008; 6 (08) 944-950.e3
    CrossrefPubMedGoogle Scholar
  • 13 Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN. Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford) 2015; 17 (08) 691-699
    CrossrefPubMedGoogle Scholar
  • 14 Okamoto T, Fujioka S, Yanagisawa S. et al. Placement of a metallic stent across the main duodenal papilla may predispose to cholangitis. Gastrointest Endosc 2006; 63 (06) 792-796
    CrossrefPubMedGoogle Scholar
  • 15 Deipolyi AR, Covey AM. Palliative percutaneous biliary interventions in malignant high bile duct obstruction. Semin Intervent Radiol 2017; 34 (04) 361-368
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Takayasu K, Muramatsu Y, Shima Y, Moriyama N, Yamada T, Makuuchi M. Hepatic lobar atrophy following obstruction of the ipsilateral portal vein from hilar cholangiocarcinoma. Radiology 1986; 160 (02) 389-393
    CrossrefPubMedGoogle Scholar
  • 17 Hadjis NS, Adam A, Gibson R, Blenkharn JI, Benjamin IS, Blumgart LH. Nonoperative approach to hilar cancer determined by the atrophy-hypertrophy complex. Am J Surg 1989; 157 (04) 395-399
    CrossrefPubMedGoogle Scholar
  • 18 Friesen BR, Gibson RN, Speer T, Vincent JM, Stella D, Collier NA. Lobar and segmental liver atrophy associated with hilar cholangiocarcinoma and the impact of hilar biliary anatomical variants: a pictorial essay. Insights Imaging 2011; 2 (05) 525-531
    CrossrefPubMedGoogle Scholar
  • 19 Perez-Johnston R, Deipolyi AR, Covey AM. Percutaneous biliary interventions. Gastroenterol Clin North Am 2018; 47 (03) 621-641
    CrossrefPubMedGoogle Scholar
  • 20 Chang WH, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 1998; 47 (05) 354-362
    CrossrefPubMedGoogle Scholar
  • 21 Inal M, Akgül E, Aksungur E, Seydaoğlu G. Percutaneous placement of biliary metallic stents in patients with malignant hilar obstruction: unilobar versus bilobar drainage. J Vasc Interv Radiol 2003; 14 (11) 1409-1416
    CrossrefPubMedGoogle Scholar
  • 22 Sutter CM, Ryu RK. Percutaneous management of malignant biliary obstruction. Tech Vasc Interv Radiol 2015; 18 (04) 218-226
    CrossrefPubMedGoogle Scholar
  • 23 Thornton RH, Frank BS, Covey AM. et al. Catheter-free survival after primary percutaneous stenting of malignant bile duct obstruction. AJR Am J Roentgenol 2011; 197 (03) W514-8
    CrossrefPubMedGoogle Scholar
  • 24 Maybody M, Brown KT, Brody LA. et al. Primary patency of Wallstents in malignant bile duct obstruction: single vs. two or more noncoaxial stents. Cardiovasc Intervent Radiol 2009; 32 (04) 707-713
    CrossrefPubMedGoogle Scholar
  • 25 Inal M, Aksungur E, Akgül E, Oguz M, Seydaoglu G. Percutaneous placement of metallic stents in malignant biliary obstruction: one-stage or two-stage procedure? Pre-dilate or not?. Cardiovasc Intervent Radiol 2003; 26 (01) 40-45
    CrossrefPubMedGoogle Scholar
  • 26 Chatzis N, Pfiffner R, Glenck M, Stolzmann P, Pfammatter T, Sharma P. Comparing percutaneous primary and secondary biliary stenting for malignant biliary obstruction: a retrospective clinical analysis. Indian J Radiol Imaging 2013; 23 (01) 38-45
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Jo JH, Park BH. Suprapapillary versus transpapillary stent placement for malignant biliary obstruction: which is better?. J Vasc Interv Radiol 2015; 26 (04) 573-582
    CrossrefPubMedGoogle Scholar
  • 28 Huang X, Shen L, Jin Y. et al. Comparison of uncovered stent placement across versus above the main duodenal papilla for malignant biliary obstruction. J Vasc Interv Radiol 2015; 26 (03) 432-437
    CrossrefPubMedGoogle Scholar
  • 29 Borges AP, Silva AV, Donato P. Comparison between suprapapillary and transpapillary uncovered self-expandable metallic stent placement for perihilar cholangiocarcinoma. J Vasc Interv Radiol 2023; 34 (08) 1400-1408
    CrossrefPubMedGoogle Scholar
  • 30 Tringali A, Hassan C, Rota M, Rossi M, Mutignani M, Aabakken L. Covered vs. uncovered self-expandable metal stents for malignant distal biliary strictures: a systematic review and meta-analysis. Endoscopy 2018; 50 (06) 631-641
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Saad WEA, Wallace MJ, Wojak JC, Kundu S, Cardella JF. Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy. J Vasc Interv Radiol 2010; 21 (06) 789-795
    CrossrefPubMedGoogle Scholar
  • 32 Quencer KB, Tadros AS, Marashi KB. et al. Bleeding after percutaneous transhepatic biliary drainage: incidence, causes and treatments. J Clin Med 2018; 7 (05) 94
    CrossrefPubMedGoogle Scholar
  • 33 Venkatanarasimha N, Damodharan K, Gogna A. et al. Diagnosis and management of complications from percutaneous biliary tract interventions. Radiographics 2017; 37 (02) 665-680
    CrossrefPubMedGoogle Scholar
  • 34 Caterino JM, Adler D, Durham DD. et al. Analysis of diagnoses, symptoms, medications, and admissions among patients with cancer presenting to emergency departments. JAMA Netw Open 2019; 2 (03) e190979
    CrossrefPubMedGoogle Scholar
  • 35 Tsai SC, Liu LN, Tang ST, Chen JC, Chen ML. Cancer pain as the presenting problem in emergency departments: incidence and related factors. Support Care Cancer 2010; 18 (01) 57-65
    CrossrefPubMedGoogle Scholar
  • 36 Coyne CJ, Reyes-Gibby CC, Durham DD. et al. Cancer pain management in the emergency department: a multicenter prospective observational trial of the Comprehensive Oncologic Emergencies Research Network (CONCERN). Support Care Cancer 2021; 29 (08) 4543-4553
    CrossrefPubMedGoogle Scholar
  • 37 Sullivan DR, Chan B, Lapidus JA. et al. Association of early palliative care use with survival and place of death among patients with advanced lung cancer receiving care in the Veterans health administration. JAMA Oncol 2019; 5 (12) 1702-1709
    CrossrefPubMedGoogle Scholar
  • 38 Vargas-Schaffer G. Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician 2010; 56 (06) 514-517 , e202–e205
    PubMedGoogle Scholar
  • 39 NCCN Guidelines Version 2.2024. Adult Cancer Pain. Accessed May 20, 2024 at: https://www.nccn.org/professionals/physician_gls/pdf/pain.pdf
    PubMedGoogle Scholar
  • 40 Elberg Dengsø K, Hillingsø J, Marcussen AM, Thomsen T. Health-related quality of life and anxiety and depression in patients diagnosed with cholangiocarcinoma: a prospective cohort study. Acta Oncol 2017; 56 (02) 198-204
    CrossrefPubMedGoogle Scholar
  • 41 Kambadakone A, Thabet A, Gervais DA, Mueller PR, Arellano RS. CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment. Radiographics 2011; 31 (06) 1599-1621
    CrossrefPubMedGoogle Scholar
  • 42 Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg 1995; 80 (02) 290-295
    PubMedGoogle Scholar
  • 43 Arcidiacono PGG, Calori G, Carrara S, McNicol ED, Testoni PA. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev 2011; 2011 (03) CD007519
    PubMedGoogle Scholar
  • 44 Lu F, Li X, Song L, Ye L, Wang X, Wang R. Efficacy and safety of celiac plexus neurolysis versus splanchnic nerve neurolysis in the management of abdominal cancer pain: a meta-analysis of 359 patients. Pain Physician 2024; 27 (01) 1-10
    PubMedGoogle Scholar
  • 45 Key BM, Tutton SM, Scheidt MJ. Cone-beam CT with enhanced needle guidance and augmented fluoroscopy overlay: applications in interventional radiology. AJR Am J Roentgenol 2023; 221 (01) 92-101
    CrossrefPubMedGoogle Scholar
  • 46 Chary A, Edalat F. Celiac plexus cryoneurolysis. Semin Intervent Radiol 2022; 39 (02) 138-141
    Article in Thieme ConnectPubMedGoogle Scholar
  • 47 Tsukamoto S, Kido A, Tanaka Y. et al. Current overview of treatment for metastatic bone disease. Curr Oncol 2021; 28 (05) 3347-3372
    CrossrefPubMedGoogle Scholar
  • 48 Huisman M, van den Bosch MAAJ, Wijlemans JW, van Vulpen M, van der Linden YM, Verkooijen HM. Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys 2012; 84 (01) 8-14
    CrossrefPubMedGoogle Scholar
  • 49 Jennings JW, Prologo JD, Garnon J. et al. Cryoablation for palliation of painful bone metastases: the MOTION multicenter study. Radiol Imaging Cancer 2021; 3 (02) e200101
    CrossrefPubMedGoogle Scholar
  • 50 Levy J, David E, Hopkins T. et al. Radiofrequency ablation provides rapid and durable pain relief for the palliative treatment of lytic bone metastases independent of radiation therapy: final results from the OsteoCool tumor ablation post-market study. Cardiovasc Intervent Radiol 2023; 46 (05) 600-609
    CrossrefPubMedGoogle Scholar
  • 51 Khanmohammadi S, Noroozi A, Yekaninejad MS, Rezaei N. Cryoablation for the palliation of painful bone metastasis: a systematic review. Cardiovasc Intervent Radiol 2023; 46 (11) 1469-1482
    CrossrefPubMedGoogle Scholar
  • 52 Kurup AN, Morris JM, Callstrom MR. Ablation of musculoskeletal metastases. AJR Am J Roentgenol 2017; 209 (04) 713-721
    CrossrefPubMedGoogle Scholar